What’s New at GRAPPA

The 2018 GRAPPA Annual Meeting and Trainee Symposium will be Thursday, July 12 (evening reception) and all day July 13 and 14 in Toronto, Canada.  If you are on a GRAPPA committee or working group that would like to have a pre- or post-meeting, please contact Pam as soon as possible to ensure there is space for your meeting.  No commercial meetings, please.  The hotel and online registration will be announced in late January.

GRAPPA Adjacent to AAD 2018 is planned for Sunday, Feb. 18 from 12 noon to 2:00 pm at the Marriott Marquis San Diego. To register, please use this link: https://grappa.memberclicks.net/grappa-adj-to-aad-2018.

GRAPPA member Wilson Bautista’s PhD thesis, “Spondyloarthritis in Colombia,” is now online at https://citroenvlinder-dtp.owncube.com/Bautista/. The work was supervised by GRAPPA members Désirée van der Heijde and Robert Landewé.
 
GRAPPA’s 2017 Annual Meeting in Amsterdam is now history but you can still review it via our newsletter at this link: newsletter.
 
Industry news:

Pfizer received approval from the US Food and Drug Administration for XELJANZ (tofacintinib) and XELJANZ® XR for the treatment of adults with active psoriatic arthritis who have had inadequate response to methotrexate or other DMARDs.  Read the news release at https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_fda_approval_of_xeljanz_tofacitinib_and_xeljanz_xr_for_the_treatment_of_active_psoriatic_arthritis
Eli Lilly now has US FDA approval for Taltz (ixekizumab) for the treatment of adults with active PSA.  Read the news release here https://investor.lilly.com/releasedetail.cfm?ReleaseID=1050469
Pfizer announced a competitive grants program, “Inflammation ASPIRE 2018 Research Awards" which invites researchers to submit proposals in RA and PsA. For more information: http://www.aspireresearch.org/Rheumatology/index.html
DO YOU HAVE NEWS?  GRAPPA members may submit news through the "Contact Us" button on this website.

GRAPPA Mission

GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients, and to enhance research, diagnosis and treatment of psoriasis and psoriatic arthritis.

Please Make a Note

2018 Annual Meeting will be in Toronto, Canada, July 12 – 14. Mark your calendars!  Online registration will open in February 2018.